Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • sanofi

    Tag: sanofi

    You Searched For "sanofi"
    Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators

    Carcinogen in popular heartburn drug Zantac triggers safety review by European, US regulators

    Medical Dialogues Bureau14 Sept 2019 9:15 AM IST
    Valisure said in its report that it found the impurity in both Sanofi SA's branded Zantac as well as generic versions of the drug. But the FDA would...
    Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

    Sanofi India sells oldest facility at Ankleshwar to Advent for Rs 262 crore

    Medical Dialogues Bureau12 Sept 2019 5:41 PM IST
    The Ankleshwar site is Sanofi India's oldest manufacturing facility where brands like Combiflam, Allegra and Amaryl are made. The production of these...
    Sanofi revival depends on outsider with nose for big drugs: Report

    Sanofi revival depends on outsider with nose for big drugs: Report

    Medical Dialogues Bureau3 Sept 2019 8:58 AM IST
    Defining Sanofi's ambitions in the cutting-edge field of gene therapies and figuring out whether to hold on to consumer health brands are among other...
    Philippines weighs re-use of Sanofi controversial dengue vaccine Dengvaxia

    Philippines weighs re-use of Sanofi controversial dengue vaccine Dengvaxia

    Medical Dialogues Bureau3 Aug 2019 9:14 AM IST
    The Philippines stopped using Dengvaxia in late 2017 and ordered Sanofi to stop selling, distributing and marketing it after Sanofi warned the vaccine...
    Sanofi strikes deal for US rights to Roche Tamiflu

    Sanofi strikes deal for US rights to Roche Tamiflu

    Medical Dialogues Bureau24 July 2019 9:15 AM IST
    Under the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
    USFDA to review Sanofi isatuximab for treatment of multiple myeloma

    USFDA to review Sanofi isatuximab for treatment of multiple myeloma

    Medical Dialogues Bureau21 July 2019 9:15 AM IST
    Sanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
    Sanofi, Google team up to discover better treatments

    Sanofi, Google team up to discover better treatments

    Medical Dialogues Bureau23 Jun 2019 9:05 AM IST
    Sanofi and Google will use data sets to improve their understanding of key diseases and extract patients' insights and feedback, the companies said in...
    GSK offers concessions to address Pfizer deal concerns

    GSK offers concessions to address Pfizer deal concerns

    Farhat Nasim23 Jun 2019 8:59 AM IST
    GSK announced the deal in December last year, a move which will put it ahead of rivals Johnson & Johnson, Bayer and Sanofi.BRUSSELS:...
    Sanofi to Partner with Google to use AI, Deep Analytics to find better treatments

    Sanofi to Partner with Google to use AI, Deep Analytics to find better treatments

    Medical Dialogues Bureau19 Jun 2019 11:58 AM IST
    PARIS: French pharmaceutical firm Sanofi said Tuesday it is partnering with Google to use artificial intelligence and deep analytics tools to sift...
    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Sanofi loses German patent case against Amgen over cholesterol drug Praluent

    Medical Dialogues Bureau9 Jun 2019 9:30 AM IST
    In the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    NPPA fixes retail price of 18 commonly used formulations including Metformin, Atorvastatin; Details

    Farhat Nasim4 Jun 2019 5:44 PM IST
    New Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Technical Committee recommends CDSCO to approve import, marketing of Sanofi TB drug with clinical trial waiver

    Farhat Nasim28 May 2019 4:21 PM IST
    New Delhi: Apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has been recommended by the Techincal Committee to granted...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok